Volume 93, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP, 2013. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 3: 3365.
    [Google Scholar]
  2. U.S. Food and Drug Administration, Expanded Access (Compassionate Use), 2015. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm431774.htm. Accessed March 22, 2015.
  3. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS, 2014. Emory serious communicable diseases unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371: 24022409.[Crossref]
    [Google Scholar]
  4. WHO, 2014. Ethical Considerations for Use of Unregistered Interventions for Ebola Virus Disease (EVD). Summary of the Panel Discussion. Available at: http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/.
    [Google Scholar]
  5. Pollack A, 2014. Opting against Ebola Drug for Ill African Doctor. New York Times. Available at: http://www.nytimes.com/2014/08/13/world/africa/ebola.html?_r=1.
    [Google Scholar]
  • Received : 18 Apr 2015
  • Accepted : 22 Apr 2015
  • Published online : 05 Aug 2015
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error